Zinivog GM 1mg/500mg/0.3mg Tablet
Marketer
Zinnia Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Zinivog GM 1mg/500mg/0.3mg Tablet
Diabeva Trio 1mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose. Diabeva Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar; discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Consistent meals and readily available fast-acting glucose (e.g., sugary snacks, juice) are essential preventative steps. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.
Primary Ingredients of Zinivog GM 1mg/500mg/0.3mg Tablet
No text was provided to rewrite.
Uses of Zinivog GM 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Zinivog GM 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Zinivog GM 1mg/500mg/0.3mg Tablet on an empty stomach.
Common Side effects of Zinivog GM 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Zinivog GM 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Zinivog GM 1mg/500mg/0.3mg Tablet should be administered on an empty stomach.
How Zinivog GM 1mg/500mg/0.3mg Tablet works:
Each Zinivog GM tablet (1mg/500mg/0.3mg) contains a triple-action antidiabetic formula.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zinivog GM 1mg/500mg/0.3mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Zinivog GM 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Zinivog GM 1mg/500mg/0.3mg Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Zinivog GM 1mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Zinivog GM 1mg/500mg/0.3mg Tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, treatment typically begins with a reduced dosage; however, Zinivog GM 1mg/500mg/0.3mg Tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Zinivog GM 1mg/500mg/0.3mg Tablet :
Should you forget a Zinivog GM 1mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zinivog GM 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently